Geoscience Reference
In-Depth Information
Table 17.7 Bulk organic and pharmaceuticals and personal care products (PPCPs) concentrations in tertiary-treated effluent and groundwater monitoring
well samples (Drewes et al.
2003
). Reprinted from Drewes et al. (
2003
). Copyright 2003 with permission of John Wiley and Sons
Tertiary-treated
effluent
OW2-90
0
(6-18 months)
NW-4
(6-18 months)
NW-2
(*16 months)
2U
(*years)
6U
([8 years)
Groundwater
background
Mean DOC
5.62
1.43
1.49
1.16
1.12
0.9
0.5
[mg/L]
(±0.87)
(±0.35)
(±0.26)
(±0.18)
(±0.11)
(±0.12)
SUVA
1.54
1.87
1.79
1.84
2.46
2.18
N/A
[L/mg m]
(±0.36)
(±0.38)
(±0.22)
(±0.37)
(±0.61)
(±0.51)
Psychomotor stimulants [ng/L]
Caffeine
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
X-ray contrast agents [lg/L]
Organic
19.3(Sun)
15.4
8
8.9
6.7
12.5
0.6
Iodine
30.5
(±0.9)
[lg I/L]
(Wed)
Lipid regulator [ng/L]
Gemifbrozil
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
Clofibric acid
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
Fenofibrate
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
Antiepileptic [ng/L]
Carbamazepine
175
115
235
125
145
85
n.d.
(±28.3)
Primidone
202
140
120
160
90
100
n.d.
(±24.75)
Analgeise/anti-inflammatory
[ng/L]
Diclofenac
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
Ibuprofen
16
n.d.
n.d.
16
n.d.
n.d.
n.d.
(±0)
Ketoprofen
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
Naproxen
8
n.d.
n.d.
n.d.
\10
\10
n.d.
(±0)
Fenoprofen
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
Propyphenazone
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
Meclofenamic acid
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
Tolfenamic acid
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
Blood viscosity agent [ng/L]
Pentoxifylline
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
